However, the effect of PKM2 agonists on the proliferation of trophoblast cells has not yet been studied, and the potential therapeutic use of PKM2 agonists to address abnormalities in glycolysis—with implications for disorders like preeclampsia—also remains to be explored. Here, PKM is linked to preeclampsia.